Chimeric antigen receptor (CAR) -T-cell therapies have yielded remarkable results in the treatment of hematological malignancies. Several autologous CAR T-cell products have received marketing ...

Chimeric antigen receptor (CAR)-T cell therapy medicinal products constitute the paradigm shift in cancer immunotherapy, employing genetic engineering to endow T cells with the capacity for precise ...

MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2–Altered ...

Researchers advance scalable stem-cell bioprocessing with AI-enabled manufacturing for regenerative medicine therapies.

It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...

As of September 26, 2024, 33 CD19 CAR T-naïve patients with LBCL (median age, 66 years; median number of previous therapies, 3) received allogeneic CAR T cells. CAR T-cell expansion was observed ...

Phase 1 Basket Study for B Cell-mediated Autoimmune Diseases to Assess FT522 as Add-on to Standard-of-care Induction and Maintenance Regimens without Conditioning Chemotherapy Initial Phase 1 Clinical ...

Automation, decentralized manufacturing, and supportive regulations are helping to surmount technical difficulties in cell and gene therapy manufacturing.

(MENAFN- EIN Presswire) EINPresswire/ -- The global primary cell supply market presents distinct product characteristics across regional suppliers. Leading international suppliers and regional ...

Streamline cell line transfer with flexible process design, data-driven strategies, and real-world insights to reduce risk ...

Global primary cell suppliers differ in species coverage. Cloud-Clone Corp. focus on various animal cells due to regional rules, ethics and material access. HUSTON ...